200 related articles for article (PubMed ID: 26944325)
1. Predictive values of vascular endothelial growth factor and microvessel-density levels in initial biopsy for prostate cancer.
Kervancioglu E; Kosan M; Erinanc H; Gonulalan U; Oguzulgen AI; Coskun EZ; Ozkardes H
Kaohsiung J Med Sci; 2016 Feb; 32(2):74-9. PubMed ID: 26944325
[TBL] [Abstract][Full Text] [Related]
2. The angiogenic switch for vascular endothelial growth factor-A and cyclooxygenase-2 in prostate carcinoma: correlation with microvessel density, androgen receptor content and Gleason grade.
Gyftopoulos K; Vourda K; Sakellaropoulos G; Perimenis P; Athanasopoulos A; Papadaki E
Urol Int; 2011; 87(4):464-9. PubMed ID: 21912077
[TBL] [Abstract][Full Text] [Related]
3. Diagnosis of isolated high-grade prostatic intra-epithelial neoplasia: proposal of a nomogram for the prediction of cancer detection at saturation re-biopsy.
Roscigno M; Scattoni V; Freschi M; Abdollah F; Maccagnano C; Galosi A; Lacetera V; Montironi R; Muzzonigro G; Deho F; Deiana G; Belussi D; Chinaglia D; Montorsi F; Da Pozzo LF
BJU Int; 2012 May; 109(9):1329-34. PubMed ID: 21895935
[TBL] [Abstract][Full Text] [Related]
4. [Diffusion weighted MRI helps evaluate angiogenesis and vascular endothelial growth factor expression in prostate cancer].
Liu JG; Wang B; Wang XZ; Niu QL; Zhang Q
Zhonghua Nan Ke Xue; 2009 May; 15(5):403-8. PubMed ID: 19514550
[TBL] [Abstract][Full Text] [Related]
5. Vascular endothelial growth factor and its correlation with angiogenesis and p53 expression in prostate cancer.
Strohmeyer D; Rössing C; Bauerfeind A; Kaufmann O; Schlechte H; Bartsch G; Loening S
Prostate; 2000 Nov; 45(3):216-24. PubMed ID: 11074523
[TBL] [Abstract][Full Text] [Related]
6. Increased expressions of vascular endothelial growth factor (VEGF), VEGF-C and VEGF receptor-3 in prostate cancer tissue are associated with tumor progression.
Yang J; Wu HF; Qian LX; Zhang W; Hua LX; Yu ML; Wang Z; Xu ZQ; Sui YG; Wang XR
Asian J Androl; 2006 Mar; 8(2):169-75. PubMed ID: 16491267
[TBL] [Abstract][Full Text] [Related]
7. [Expression of hypoxia-inducible factor 1 alpha and vascular endothelial growth factor in prostate cancer and its significance].
Wang L; Chen ZJ; Wang QT; Cao WF; Jian Y; Wang SX; Zhang BH
Zhonghua Nan Ke Xue; 2006 Jan; 12(1):57-9. PubMed ID: 16483162
[TBL] [Abstract][Full Text] [Related]
8. The expression of hypoxia-inducible factor-1alpha (HIF-1alpha) and angiogenesis markers in hyperplastic and malignant prostate tissue.
Lekas A; Lazaris AC; Deliveliotis C; Chrisofos M; Zoubouli C; Lapas D; Papathomas T; Fokitis I; Nakopoulou L
Anticancer Res; 2006; 26(4B):2989-93. PubMed ID: 16886625
[TBL] [Abstract][Full Text] [Related]
9. Expression of bFGF, VEGF and c-met and their correlation with microvessel density and progression in prostate carcinoma.
Strohmeyer D; Strauss F; Rössing C; Roberts C; Kaufmann O; Bartsch G; Effert P
Anticancer Res; 2004; 24(3a):1797-804. PubMed ID: 15274358
[TBL] [Abstract][Full Text] [Related]
10. Expression of pro-angiogenic growth factors VEGF, EGF and bFGF and their topographical relation to neovascularisation in prostate cancer.
Trojan L; Thomas D; Knoll T; Grobholz R; Alken P; Michel MS
Urol Res; 2004 May; 32(2):97-103. PubMed ID: 15250102
[TBL] [Abstract][Full Text] [Related]
11. Microvessel density and expression of vascular endothelial growth factor in clinically localized prostate cancer.
Łuczyńska E; Gasińska A; Wilk W
Pol J Pathol; 2013 Apr; 64(1):33-8. PubMed ID: 23625598
[TBL] [Abstract][Full Text] [Related]
12. Diagnosis of high-grade prostatic intraepithelial neoplasia: the impact of the number of biopsy cores at initial sampling on cancer detection after a saturation re-biopsy.
Roscigno M; Scattoni V; Freschi M; Raber M; Angiolilli D; Galosi A; Lacetera V; Montironi R; Muzzonigro G; Deho F; Feroldi L; Deiana G; Chinaglia D; Montorsi F; Da Pozzo LF
Arch Ital Urol Androl; 2010 Dec; 82(4):242-7. PubMed ID: 21341572
[TBL] [Abstract][Full Text] [Related]
13. Expression of different vascular endothelial markers in prostate cancer and BPH tissue: an immunohistochemical and clinical evaluation.
Trojan L; Thomas D; Friedrich D; Grobholz R; Knoll T; Alken P; Michel MS
Anticancer Res; 2004; 24(3a):1651-6. PubMed ID: 15274336
[TBL] [Abstract][Full Text] [Related]
14. Dynamic contrast-enhanced MRI of benign prostatic hyperplasia and prostatic carcinoma: correlation with angiogenesis.
Ren J; Huan Y; Wang H; Chang YJ; Zhao HT; Ge YL; Liu Y; Yang Y
Clin Radiol; 2008 Feb; 63(2):153-9. PubMed ID: 18194690
[TBL] [Abstract][Full Text] [Related]
15. Expression of vascular endothelial growth factor (VEGF) and association with microvessel density in benign prostatic hyperplasia and prostate cancer.
Stefanou D; Batistatou A; Kamina S; Arkoumani E; Papachristou DJ; Agnantis NJ
In Vivo; 2004; 18(2):155-60. PubMed ID: 15113042
[TBL] [Abstract][Full Text] [Related]
16. Angiogenesis and prostate cancer: in vivo and in vitro expression of angiogenesis factors by prostate cancer cells.
Ferrer FA; Miller LJ; Andrawis RI; Kurtzman SH; Albertsen PC; Laudone VP; Kreutzer DL
Urology; 1998 Jan; 51(1):161-7. PubMed ID: 9457313
[TBL] [Abstract][Full Text] [Related]
17. Differential expression of angiopoietin-2 and vascular endothelial growth factor in androgen-independent prostate cancer models.
Tesan T; Gustavsson H; Welén K; Damber JE
BJU Int; 2008 Sep; 102(8):1034-9. PubMed ID: 18489523
[TBL] [Abstract][Full Text] [Related]
18. Plasma vascular endothelial growth factors A and C in patients undergoing prostatic biopsy and TURP for suspected prostatic neoplasia.
Singh A; Gautam KA; Dalela D; Sankhwar S; Natu S; Sankhwar P; Srivastava A
Asian Pac J Cancer Prev; 2013; 14(3):2053-8. PubMed ID: 23679318
[TBL] [Abstract][Full Text] [Related]
19. Association between immunohistochemical expression of vascular endothelial growth factor (VEGF), VEGF-expressing neuroendocrine-differentiated tumor cells, and outcome in prostate cancer patients subjected to watchful waiting.
Borre M; Nerstrøm B; Overgaard J
Clin Cancer Res; 2000 May; 6(5):1882-90. PubMed ID: 10815911
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of serum vascular endothelial growth factor (VEGF) and microvessel density (MVD) as prognostic indicators in carcinoma breast.
Shivakumar S; Prabhakar BT; Jayashree K; Rajan MG; Salimath BP
J Cancer Res Clin Oncol; 2009 Apr; 135(4):627-36. PubMed ID: 18936974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]